Despite D-Wave Quantum’s (QBTS) considerable strengths, a rival quantum computing firm is drawing stronger attention from investors and analysts alike.
D-Wave brings a compelling profile to the table, including promising technologies, rapidly growing bookings and backlog, U.S. government investment, and an impressive customer roster.
Among D-Wave’s major customers are Toyota (TM), Deloitte, Mastercard (MA), and Volkswagen (VWAGY), representing a broad cross-section of global industries relying on quantum solutions.
Canada-based BMO Capital recently expressed a bullish stance on D-Wave, citing the company’s dual capability in both annealing and gate-model quantum systems.
According to BMO, “Having both technologies allows QBTS to address different quantum applications and significantly increases the size of its potential market.”
BMO also cited Boston Consulting Group data placing D-Wave’s total addressable market somewhere between $450 billion and $850 billion, a staggering potential opportunity.
However, Quantinuum (QNT), which went public through a majority-owner Honeywell (HON) IPO launch, matches D-Wave on many of these same strengths while exceeding it on key financial metrics.
Quantinuum’s revenue, backlog, and cash reserves are all meaningfully larger than those of D-Wave, giving the company a more substantial financial foundation heading into a competitive period for the sector.
As of the end of the second quarter, Quantinuum held $546 million in cash, providing a significant liquidity cushion for ongoing research and commercial expansion.
The company appears to be making notable progress in the pharmaceutical and medical sectors, areas widely seen as among the most valuable near-term opportunities for quantum computing applications.
Quantinuum reported in its second-quarter earnings that it had “Demonstrated, with NVIDIA and a Fortune 100 pharma company, how AI-driven quantum simulation can potentially enhance molecular property characterization in pharmaceutical applications.”
That collaboration with NVIDIA signals deepening ties between quantum computing and artificial intelligence, a combination investors increasingly view as central to near-term commercial viability.
D-Wave remains a credible and well-positioned player in the quantum space, and its dual-technology approach gives it flexibility that many single-method competitors cannot match.
Still, Quantinuum’s sizable cash moat, larger backlog, and high-profile industry partnerships make it the stronger and safer choice for investors looking to gain quantum sector exposure right now.
